These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22991352)

  • 1. Most important outcomes research papers on anticoagulation for cardiovascular disease.
    Bikdeli B; Gupta A; Mody P; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):e65-74. PubMed ID: 22991352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most important papers in health costs, cost-effectiveness, and resource utilization.
    Dharmarajan K; Lampropulos J; Bikdeli B; Mody P; Gupta A
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):e9-15. PubMed ID: 22438466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most important articles on cardiovascular disease among racial and ethnic minorities.
    Mody P; Gupta A; Bikdeli B; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):e33-41. PubMed ID: 22811508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most important outcomes research papers in cardiovascular disease in the elderly.
    Gupta A; Mody P; Bikdeli B; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):e17-26. PubMed ID: 22592757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most important outcomes research papers on treatment of stable coronary artery disease.
    Bikdeli B; Ranasinghe I; Chen R; Gupta A; Lampropulos JF; Kulkarni VT; Mody PS; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):e17-25. PubMed ID: 23674308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most important outcomes research papers on hypertension.
    Chen R; Dharmarajan K; Kulkarni VT; Punnanithinont N; Gupta A; Bikdeli B; Mody PS; Ranasinghe I
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):e26-35. PubMed ID: 23838106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding complications in patients on anticoagulants who would have been disqualified for clinical trials.
    Levi M; Hovingh K
    Thromb Haemost; 2008 Dec; 100(6):1047-51. PubMed ID: 19132229
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
    Ageno W; Spyropoulos AC; Turpie AG
    Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quest for new anticoagulants: from clinical development to clinical practice.
    Apostolakis S; Lip GY; Lane DA; Shantsila E
    Cardiovasc Ther; 2011 Dec; 29(6):e12-22. PubMed ID: 20553291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the warfarin saga over?
    Schulman S
    J R Coll Physicians Edinb; 2012 Mar; 42(1):51-5. PubMed ID: 22441066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-control of long-term oral anticoagulation using a point-of-care device.
    Roudaut R
    Arch Cardiovasc Dis; 2008; 101(11-12):683-4. PubMed ID: 19059561
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
    Hull RD
    Thromb Haemost; 2008 Mar; 99(3):502-10. PubMed ID: 18327398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anti-coagulant therapies set to revitalise clinical haemotology practice.
    Aalbers J; Wagenaar P; Klug E
    Cardiovasc J Afr; 2010; 21(6):323-6, 337. PubMed ID: 21135980
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ; van Hattum ES
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.
    Huisman MV; Lip GY; Diener HC; Brueckmann M; van Ryn J; Clemens A
    Thromb Haemost; 2012 May; 107(5):838-47. PubMed ID: 22318514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evolution of Antithrombotic Care in Cardiovascular Patients.
    Camm AJ
    Thromb Haemost; 2018 May; 118(S 01):S1. PubMed ID: 29566412
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
    Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
    Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.
    Coyle D; Coyle K; Cameron C; Lee K; Kelly S; Steiner S; Wells GA
    Value Health; 2013 Jun; 16(4):498-506. PubMed ID: 23796283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.